Qure.ai nets $65M for foundational AI Qure.ai has raised $65 million in a Series D funding round led by Lightspeed and 360 ONE Asset.
The company said it will use its fresh funds to invest more in foundational…
Healthcare AI startup Qure.ai closed a $65 million Series D financing round on Wednesday. The startup — which is headquartered in India — plans to use the capital to expand its presence in the…
Continue Reading
What You Should Know:
– Qure.ai, a prominent global innovator in healthcare AI, has successfully closed a $65M in Series D funding round led by Lightspeed and 360 ONE Asset, with contributions from Merck Global…
Continue Reading
What You Should Know:
– A new study presented at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer offers exciting possibilities for early lung cancer detection.
– Researchers…
Continue Reading
Introduction
Lung cancer remains one of the leading causes of cancer-related deaths worldwide, primarily due to the challenges in early detection and monitoring. However, the recent advancements in artificial intelligence (AI) are revolutionizing lung cancer…
What You Should Know:
– Qure.ai, a global innovator in medical imaging AI, has today announced a pivotal 510(k) FDA clearance for its AI-powered chest CT solution – qCT LN Quant.
– The new AI solution is now…
Continue Reading
What You Should Know:
– Merck Global Health Innovation Fund (MGHIF), a leader in healthcare impact investing, announced a strategic investment in Qure.ai, a prominent developer of artificial intelligence (AI) solutions for medical imaging.
– The…
Continue Reading
Clinicians at NHS Greater Glasgow and Clyde are now using a head CT AI solution from Qure.ai to support faster decision-making about the care, management and discharge of patients with head injuries. Healthcare clinicians…
Continue Reading
University Hospitals of Leicester NHS Trust has gone live with an AI-powered chest x-ray solution, as part of the multi-NHS site LungIMPACT research study.The trust is using Qure.ai’s qXR AI which is integrated into…
Continue Reading
Qure.ai, a leader in medical imaging AI, achieves FDA breakthrough device status for its qSpot-TB solution, enhancing its regulatory standing alongside four FDA clearances and 61 EU MDR CE marks within 18 months. qSpot-TB,…
Continue Reading
